Under the ASR agreements Janssen Pharmaceutical will purchase shares of Johnson & Johnson common stock that the banks will have borrowed from stock lenders, and during the term of the ASR agreements the banks are expected to …
Shares closed up 0.9% at $112.80 on Wednesday and were indicated down 0.5% at $112.28 on Thursday. Johnson &
Shares of Actelion Ltd.(ALIOF.PK) were gaining around 21 percent in the morning trading after the Swiss biotechnology firm on Thursday agreed to a $30 billion takeover by drug major Johnson & Johnson (JNJ). Immediately prior to the …
Johnson & Johnson (NYSE: JNJ) is a healthcare giant that sells over-the-counter products, pharmaceuticals, and medical devices. Its diversification makes it a core holding for many investors, including income investors who love its …
SOMERVILLE, N.J., Aug. 23-- Johnson and Johnson issued the following news release: Spectrum Health realized …
Johnson & Johnson’s bid for Synthes, a Swiss-American medical equipment manufacturer, makes a lot of strategic sense. The $21.3 billion deal will give Johnson & Johnson a leading position in the main orthopedic device markets. …
NEW YORK – The U.S. stock market is down at midday, hit by a combination of lower earnings at Johnson &